Venous thromboembolism and bleeding in critically ill COVID-19 patients treated with higher than standard low molecular weight heparin doses and aspirin: a call to …

V Pavoni, L Gianesello, M Pazzi, C Stera, T Meconi… - Thrombosis research, 2020 - Elsevier
Background Critically ill COVID-19 patients have a clear pattern of inflammation and
hypercoagulable state. The main aim of the study was to evaluate the outcome of severe …

Venous thromboembolism and bleeding in critically ill COVID-19 patients treated with higher than standard low molecular weight heparin doses and aspirin: A call to …

V Pavoni, L Gianesello, M Pazzi… - Thrombosis …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Critically ill COVID-19 patients have a clear pattern of inflammation and
hypercoagulable state. The main aim of the study was to evaluate the outcome of severe …

[PDF][PDF] Venous thromboembolism and bleeding in critically ill COVID-19 patients treated with higher than standard low molecular weight heparin doses and aspirin: A …

V Pavoni, L Gianesello, M Pazzi, C Stera… - Thrombosis …, 2020 - academia.edu
Background: Critically ill COVID-19 patients have a clear pattern of inflammation and
hypercoagulable state. The main aim of the study was to evaluate the outcome of severe …

[HTML][HTML] Venous thromboembolism and bleeding in critically ill COVID-19 patients treated with higher than standard low molecular weight heparin doses and aspirin: A …

V Pavoni, L Gianesello, M Pazzi, C Stera… - Thrombosis …, 2020 - ncbi.nlm.nih.gov
Background Critically ill COVID-19 patients have a clear pattern of inflammation and
hypercoagulable state. The main aim of the study was to evaluate the outcome of severe …

Venous thromboembolism and bleeding in critically ill COVID-19 patients treated with higher than standard low molecular weight heparin doses and aspirin: A call to …

V Pavoni, L Gianesello, M Pazzi… - Thrombosis …, 2020 - thrombosisresearch.com
Background Critically ill COVID-19 patients have a clear pattern of inflammation and
hypercoagulable state. The main aim of the study was to evaluate the outcome of severe …

Venous thromboembolism and bleeding in critically ill COVID-19 patients treated with higher than standard low molecular weight heparin doses and aspirin: a call to …

V Pavoni, L Gianesello, M Pazzi, C Stera, T Meconi… - 2020 - cabidigitallibrary.org
Background: Critically ill COVID-19 patients have a clear pattern of inflammation and
hypercoagulable state. The main aim of the study was to evaluate the outcome of severe …

Venous thromboembolism and bleeding in critically ill COVID-19 patients treated with higher than standard low molecular weight heparin doses and aspirin: A call to …

V Pavoni, L Gianesello, M Pazzi, C Stera… - Thrombosis …, 2020 - europepmc.org
Background Critically ill COVID-19 patients have a clear pattern of inflammation and
hypercoagulable state. The main aim of the study was to evaluate the outcome of severe …